Screening of urocanic acid isomers in human basal and squamous cell carcinoma tumors compared with tumor periphery and healthy skin

Experimental Dermatology

Volumn 17, Issue 10, 2008, Pages 806-812

  Decara, Juan Manuel ^a   Aguilera, José ^b,c   Abdala, Roberto ^c   Sánchez, Purificación ^b   Figueroa, Félix L ^c   Herrera, Enrique ^b,d  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b UNIVERSIDAD DE MÁLAGA   (Spain)

^c UNIVERSITY OF MÁLAGA   (Spain)

^d Servicio de Dermatologia   (Spain)

Author keywords

Human skin; Non melanoma skin cancer; Photoisomerization; Urocanic acid

Indexed keywords

DNA; UROCANIC ACID;

ABDOMEN; ADOLESCENT; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER SCREENING; CHEEK; CONTROLLED STUDY; DNA DAMAGE; FEMALE; FOREARM; FOREHEAD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOMODULATION; ISOMER; MAJOR CLINICAL STUDY; MALE; RADIATION EXPOSURE; SKIN BIOPSY; SKIN CARCINOGENESIS; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; THIGH; ULTRAVIOLET RADIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; EPIDERMIS; FEMALE; HUMANS; IMMUNE TOLERANCE; ISOMERISM; MALE; MIDDLE AGED; SKIN NEOPLASMS; ULTRAVIOLET RAYS; UROCANIC ACID; YOUNG ADULT;

EID: 51949094852     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00695.x     Document Type: Article

References (38)

1. Zenisek A, Kral JA, Hais IM. Sun-screening effect of urocanic acid. Biochim Biophys Acta 1955: 18: 589-591.
2. De Fabo EC, Noonan FP. Mechanism of immune suppression by ultraviolet irradiation in vivo. I. Evidence for the existence of a unique photoreceptor in skin and its role in photoimmunology. J Exp Med 1983: 158: 84-98.
3. Reeve VE, Mitchell LE. Hazards of urocanic acid as a cosmetic ingredient. Photodermatol Photoimmunol Photomed 1991: 8: 176-180.
4. Noonan FP, De Fabo EC. Immunosuppression by ultraviolet B radiation: initiation by urocanic acid. Immunol Today 1992: 13: 250-254.
5. Norval M, Gibbs NK, Gilmour J. The role of urocanic acid in UV-induced immunosuppression: Recent advances (1992-1994). Photochem Photobiol 1995: 62: 209-217.
6. Ullrich SE. Modulation of immunity by ultraviolet radiation: Key effects on antigen presentation. J Invest Dermatol 1995: 105: 1.
7. Beissert S, Mohammad T, Torri H et al. Regulation of tumor antigen presentation by urocanic acid. J Immunol 1997: 159: 92-96.
8. De Fine Olivarius F, Lock-Andersen J, Larsen FG, Wulf HC, Crosby J, Norval M. Urocanic acid isomers in patients with basal cell carcinoma and cutaneous malignant melanoma. Br J Dermatol 1998: 138: 986-992.
9. Reeve VE, Greenoak GE, Canfield PJ, Boehm-Wilcox C, Gallagher CH. Topical urocanic acid enhances UV-induced tumor yield and malignancy in the hairless mouse. Photochem Photobiol 1989: 49: 459-464.
10. Baden HP, Mittler B, Sviokla S, Pathak MA. Urocanic acid in benign and malignant human epidermal tumors. J Natl Cancer Inst 1967: 38: 205-208.
11. Domarus HV, Stevens PJ. Metastatic basal cell carcinoma: Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol 1984: 10: 1043-1060.
12. Marks R. Non-melanoma skin cancer and solar keratoses in Australia - a review. Eur J Epidemiol 1985: 1: 319-322.
13. Snellman E, Xu G, Pasanen P, Laihia J, Hemminki K. Correlation analysis of production and photoisomerization of epidermal urocanic acid versus induction and repair of DNA photoproducts in the human skin in situ. J Invest Dermatol 2002: 118: 893-895.
14. Beissert S, Mohammad T, Torri H et al. Regulation of tumor antigen presentation by urocanic acid. J Immunol 1997: 159: 92-96.
15. Reeve VE, Greenoak GE, Canfield PJ, Boehm-Wilcox C, Gallagher CH. Topical urocanic acid enhances UV-induced tumor yield and malignancy in the hairless mouse. Photochem Photobiol 1989: 49: 459-464.
16. Fitzpatrick B. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988: 124: 869-871.
17. Hermann K, Abeck D. Analysis of histidine and urocanic acid isomers by reversed-phase high performance liquid chromatography. J Chromatogr B Biomed Sci Appl 2001: 750: 71-80.
18. Sokal RR, Rohlf FJ. Biometry: The Principles and Practice of Statistics in Biological Research, 3rd edn. New York: WH Freeman and Co., 1995.
19. Jansen CT, Lammintausta K, Pasanen P et al. A non-invasive chamber sampling technique for HPLC analysis of human epidermal urocanic acid isomers. Acta Derm Venereol (Stockh) 1991: 71: 143-145.
20. Stab F, Hoppe U, Sauermann G. Urocanic acid and its function in endogenous antioxidant defense and UV-protection in human skin. J Investig Dermatol 1994: 102: 666.
21. De Fine Olivarius F, Wulf HC, Therkildsen P, Poulsen T, Crosby J, Norval M. Urocanic acid isomers: Relation to body site, pigmentation, stratum conium thickness and photosensitivity. Arch Dermatol Res 1997: 289: 501-505.
22. Hais M, Strych A, Spacek J, Zenisek A, Kral JA. The increase of epidermal imidazoleacrylic acid following isolation. J Invest Dermatol 1970: 55: 39-46.
23. Snellman E, Koulu L, Pasanen P et al. Effect of psoriasis heliotherapy on epidermal urocanic acid isomer concentrations. Acta Derm Venereol (Stockholm) 1992: 72: 231-233.
24. Gilmour JW, Vestey JP, Norval M. The effect of UV therapy on immune function in patients with psoriasis. Br J Dermatol 1993: 129: 28-38.
25. Baden HP, Pathak MA. The metabolism and function of urocanic acid in keratinising tissue. Bichim Biophys Acta 1965: 104: 200-204.
26. Kavanag G, Crosby J, Norval M. Urocanic acid isomers in human skin: analysis of site variation. Br J Dermatol 1995: 133: 728-731.
27. Zenisek K, Kral AJ. The occurrence of urocanic acid in human sweat. Biochim Biophys Acta 1953: 12: 479-480.
28. Baden HP, Mittle B, Sviokla S, Pathak MA. Urocanic acid in benign and malignant human epidermal tumors. J Natl Cancer Inst 1967: 38: 205-208.
29. Baden HP, Mittle B, Sviokla S, Pathak MA. Histidase activity in hyperplastic and neoplastic rat epidermis and liver. Cancer Res 1968: 28: 1463-1468.
30. Scott IR. Factors controlling the expressed activity of histidine ammonia-lyase in the epidermis and the resulting accumulation of urocanic acid. Biochem J 1981: 15: 829-38.
31. De Simone C, Masini C, Cattaruzza MS, Guerriero C, Cerimele D, Norval M. Urocanic acid isomers in patients with non-melanoma skin cancer. Br J Dermatol 2001: 144: 858-861.
32. Ross JA, Howie SE, Norval M, Maingay J, Simpson TJ. Ultraviolet-irradiated urocanic acid suppresses delayed-type hypersensitivity to herpes simplex virus in mice. J Invest Dermatol 1986: 87: 630-633.
33. Norval M, Simpson TJ, Ross JA. Urocanic acid and immunosuppression. Photochem Photobiol 1989: 50: 84-98.
34. Kurimoto I, Streilein JW. Cis-urocanic acid suppression of contact hypersensitivity induction is mediated via tumour necrosis factor-alpha. J Immunol 1992: 148: 3072-3078.
35. Prater MR, Blaylock BL, Holladay SD. Molecular mechanisms of cis-urocanic acid and permethrin-induced alterations in cutaneous immunology. Photodermatol Photoimmunol Photomed 2003: 19: 287-2.
36. Jaksic A, Finlay-Jones JJ, Watson CJ, Spencer LK, Santucci I, Hart PH. Cis-urocanic acid synergizes with histamine for increased PGE2 production by human keratinocytes: Link to indomethacin-inhibitable UVB-induced immunosuppression. Photochem Photobiol 1995: 61: 303-309.
37. Walterscheid JP, Nghiem DX, Kazimi N et al. Cis -urocanic acid, a sunlight-induced immunosuppressive factor, activates immune suppression via the 5-HT 2A receptor. Proc Natl Acad Sci USA 2006: 103: 17420-17425.
38. Kamstrup MR, Gniadecki R, Skovgaard G. Putative cancer stem cells in cutaneous malignancies. Exp Dermatol 2007: 16: 297-301.